Itch is defined as the sensation that causes the desire to scratch, and it can be induced by mechanical, thermal and chemical stimuli. We do not understand the biological and evolutionary advantages of scratching an itch. But we do know that chronic or severe acute itch causes needless suffering that is often difficult to alleviate 1 . If we better understood the sensory neuronal conditions that are unique to itch -including the particular neurons involved and their molecular and functional properties -we might be able to devise better methods for the selective prevention and treatment of itch.
. If we better understood the sensory neuronal conditions that are unique to itch -including the particular neurons involved and their molecular and functional properties -we might be able to devise better methods for the selective prevention and treatment of itch.
In this Review, we focus on itch-related studies in humans, monkeys and mice, and specifically on the activity of peripheral sensory neurons and neurons of the spinothalamic tract (STT) that carry information about pruritic (itchy) chemical stimuli from the spinal cord to the thalamus -a major sensory gateway to the cerebral cortex. Specifically, we focus on the types of sensory neurons that encode pruritic chemical stimuli. We ask whether they exhibit unique molecular markers that could be used for the identification and characterization, targeted cell ablation or manipulation of their physiological properties. Finally, we consider the endogenous neural mechanisms that act to suppress or enhance the transmission of pruritic information in the spinal or medullary dorsal horn.
There is a surprising diversity in the capacities of sensory neurons to respond to different types of pruritic chemicals. However, it seems that both peripheral and central pruriceptive neurons are subsets of a larger population of neurons that respond to noxious stimuli, which raises a fundamental question: what information is used by the brain to decode neuronal activity in populations of neurons as 'itch' rather than 'pain'? One way to address this issue is to assess the input that populations of peripheral sensory neurons provide to the neuronal cells in the spinal or medullary dorsal horn -that is, to the populations of interneurons that modulate sensory transmission and the projection neurons that transmit the information to the brain.
In this Review, we summarize current knowledge of the neuronal mechanisms underlying the sensation of itch in humans or itch-like behaviours in animals in response to pruritic chemicals applied to the skin. We refer readers interested in additional information on the mechanisms of itch, its peripheral mediators and its clinical treatment to additional reviews on these topics [2] [3] [4] .
Responses to pruritic agents
The neural mechanisms of itch have been investigated by directly relating measurements of itch in humans, or itch-like behaviour in animals, to the responses of sensory neurons to the same set of stimuli. Usually, these studies use chemical agents that elicit sustained itch or pain in humans and induce behaviours that are thought to reflect the presence of itch in animals. These chemicals are also applied to isolated cells in vitro to study, for example, mechanisms of transduction.
Histamine has been the 'gold standard' pruritic agent in many experimental studies of itch [5] [6] [7] . However, most types of pruritic disorders are poorly treated with antihistamines 8 , and the experimental use of histamineindependent pruritogens may therefore help to unravel causes of pathological itch. Some non-histaminergic Nature Reviews | Neuroscience These and other pruritogens can be applied in a similar manner and at similar concentrations in psychophysical experiments in humans and in behavioural and neuronal studies in animals, enabling direct comparisons between species. One caveat is that the site-directed responses used as behavioural indicators of itch in animals, such as scratching or biting, or indicators of pain, such as wiping or licking, produce tactile and nociceptive sensory stimulation that can modulate the sensations that the experimenter wishes to measure. These site-directed responses are therefore indirect indicators of sensation. By contrast, sensations in humans and neuronal electrophysiological activity in neurons are recorded in the absence of itch-or pain-altering site-directed stimulation. By identifying the magnitude and time course of different qualities of sensation in humans, it has been possible to define and characterize the sensory information that is represented by the electrophysiologically recorded responses of sensory neurons that encode pruritic and algesic chemicals. Humans, monkeys and mice respond differently to chemical agents that are predominantly pruritic than they do to those that are painful. a | The graph shows mean ratings of perceived intensity of itch by humans in response to injection of histamine and to the application of various chemical agents that evoke a histamine-independent itch, including cowhage spicules, β-alanine injection, bovine adrenal medulla 8-22 peptide (BAM8-22) and capsaicin (the latter two were delivered by means of a heat-inactivated cowhage spicule). These are compared to the perceived intensity of burning elicited by a painful injection of capsaicin. Subjects moved a cursor along a labelled magnitude scale that ranged from 'no sensation' to 'strongest imaginable sensation of any kind'. Four of the descriptor labels are shown on the right vertical axis in correspondence with the numerical ratings of perceived intensity indicated on the left vertical axis. b | Cutaneous administration of histamine and active cowhage spicules induces scratching behaviour in monkey (n = 3). Scratching was not observed after the application of saline, inactive cowhage spicules or capsaicin and its vehicle. The number of scratches was counted by a blinded observer for 30 min after stimulus application. Error bars indicate mean ± SEM. c | Mice, like humans, respond differently to injections of histamine (green) and capsaicin (red). In the left panel, for each of 15 humans, the area under the intensity-time rating curve (area under curve (auc)) for itch was plotted against the auc for nociceptive sensations (these included pricking and/or stinging or burning (whichever was judged to be greater at the time of a given rating)) in response to histamine or capsaicin at a given dose injected into the forearm. In the right panel, for each of 8-10 mice, the number of bouts of scratching in 20 min was plotted against the number of wipes directed toward the site of injection in the cheek in 20 min for a given dose of histamine or capsaicin. Panel a is modified, with permission, from REF. 
Pruriceptors
Nociceptors that respond to one or more pruritic chemicals.
Cutaneous receptive fields
Areas of skin within which a stimulus activates a sensory neuron, for example, by evoking action potentials.
When humans judged and directly compared the perceived intensities of itch and the nociceptive sensory qualities of pricking and/or stinging and burning on a single scale of sensory magnitude (that is, a labelled magnitude scale), the itch in response to histamine and to non-histaminergic pruritic agents (such as native cowhage spicules, capsaicin delivered by a single spicule and β-alanine) was similar in magnitude and time course 7, [9] [10] [11] [12] [13] (FIG. 1a) . The itch induced by each pruritogen was typically accompanied by slightly weaker and shorter lasting nociceptive sensations of pricking and/or stinging, and burning. The itch and nociceptive sensations were positively correlated in magnitude. In contrast to the sensory effects of pruritogens, an intradermal injection of capsaicin elicited pain described as pricking and/or stinging and burning but resulted in virtually no itch 7, 18 . Analogously, different types of behaviour are elicited when agents rated by humans as more pruritic than nociceptive (or vice versa) are applied to the skin of a monkey 14 (FIG. 1b) or a mouse [15] [16] [17] (FIG. 1c) . These findings show that the qualitatively different behaviours that are evoked in animals by stimuli that humans describe as primarily itchy or painful help to validate the association of a neural mechanism in animals with one or the other of these sensory qualities.
Diversity of pruriceptive nociceptors
Electrophysiological in vivo recordings from peripheral sensory neurons in humans, monkeys or mice indicate that pruritic chemicals applied to the skin elicit action potentials in a subset of nociceptors 14, [18] [19] [20] [21] [22] [23] . These pruriceptive nociceptive neurons (or pruriceptors) and the nociceptive neurons that do not respond to pruritic chemicals (non-pruriceptive nociceptors) can be further subclassified according to their responsiveness to noxious mechanical, thermal or chemical stimuli. For example, mechano-sensitive nociceptive afferents (MSAs) that respond to noxious mechanical stimuli are distinguished from those that are mechano-insensitive (MIAs). The axons of nociceptive neurons can be unmyelinated and slowly conducting (these are known as C-fibres, such as the C-fibre mechanoheat-sensitive nociceptors (CMHs)) or thinly myelinated and faster conducting (these are known as A-fibres, such as the A-fibre mechanoheatsensitive nociceptors (AMHs)).
Non-pruriceptive nociceptors. There is no evidence for the existence of peripheral sensory neurons that are itchspecific; that is, responsive only to pruritic but not to algesic stimuli. However, non-pruriceptive nociceptive neurons have been identified that are unresponsive to pruritic chemicals. These include high-threshold nociceptors with C-or A-fibres that are activated only by noxious mechanical stimuli, heat or capsaicin 14, [18] [19] [20] [21] [22] [23] [24] . In humans, for example, some of the MIAs supplying the skin include C-fibres with nociceptors that are insensitive to both cowhage and histamine but are activated by noxious heat and/or capsaicin. The discharge rates of these neurons, which could not be determined directly owing to a low signal-to-noise ratio, have been assessed indirectly by counting the number of 'activation periods' after stimulus application. The activation periods display a time course that is similar to that of the sensations of pain reported 18, 25 . MIAs have also been identified in monkeys (in which they are composed of C-and A-fibres) 26 ,27 and mice (in which they are composed only of C-fibres) 28 , but there are fewer tests of their responses to pruritogens. Thus, non-pruriceptive nociceptors mainly seem to contribute to pain signalling; nevertheless, a possible role for these neurons in itch has not been ruled out.
Pruriceptors responsive to histamine. Histamine activates subsets of MIAs such as those with C-fibre nociceptors that are responsive to heat or to capsaicin 6, 18 and, less effectively, MSAs with A-or C-fibres (AMs and CMs). Some MSAs are also responsive to heat (MHs or, more specifically, CMHs and AMHs) 14, 19, [21] [22] [23] 29 . In vivo recordings of neural activity evoked by histamine have been obtained from peripheral nerve fibres in monkeys and humans and from dorsal root ganglion (DRG) neurons in mice. The neuronal responses of C-fibre MIAs in humans 6, 18 , CMHs in mice 23 , and CMHs and AMs in monkeys 14, 22 exhibit temporal profiles that generally match the time course of itch in humans 6, 7, 11 , suggesting that activity in these afferents may contribute to histamine-induced itch. However, the histamine-induced activity in CMHs is weak 14 . Taking advantage of the fact that C-fibre MIAs have larger cutaneous receptive fields than CMHs 24 , it was found that after blocking a cutaneous nerve with a local anaesthetic, histamineinduced itch and pain in response to electrical but not mechanical stimuli could be elicited from an area adjacent to the completely anaesthetized region of skin, presumably by activating C-fibre MIAs that originated from neighbouring, unblocked nerves. It was concluded that C-fibre MIAs alone may be sufficient to mediate histamine-induced itch 30 . Currently, it is not possible to selectively block conduction in MIAs to investigate the role of mechano-sensitive pruriceptors in histamineinduced itch.
In mice, the cutaneous sensory neurons that respond to histamine include, but are not limited to 29, 31 , those that express Mas-related G-protein-coupled receptor member A3 (MRGPRA3), the receptor for chloroquine, an antimalarial drug that is linked to pruritus in patients with malaria who have with dark skin and to itch-like behaviour in mice 29, 32 . Sensory neurons that are responsive to chloroquine are also activated by, and express the corresponding receptors for, histamine (the ligand for the H1 receptor), BAM8-22 (the ligand for the receptor MRGPRC11), SLIGRL-NH2 (a peptide agonist for proteinase-activated receptor 2 (PAR2), which evokes itch behaviour by activating MRGPRC11) 33 , capsaicin (which acts on transient receptor potential vanilloid 1 (TRPV1)) 29 and serotonin (FIG. 2) . Each receptor may also be linked to different effector molecules by distinct signalling pathways 34, 35 . For example, histamine can signal through TRPV1 (REF. 36), and chloroquine and BAM8-22 can signal through separate pathways to activate the transient receptor potential cation channel ankyrin 1 (TRPA1) 37, 38 . Nature Reviews | Neuroscience TRPV1 and TRPA1 are ion channels that can also be directly activated by algesic chemicals: for example, TRPV1 can be activated by capsaicin and TRPA1 is primarily activated by electrophilic irritants such as allyl isothiocyanate. The DRG neurons that express TRPA1 are mostly a subpopulation of those expressing TRPV1 (REFS 39, 40) and both channels have roles in neuronal excitation, hypersensitivity and the release of inflammatory neuropeptides 41 . Only 5% of DRG neurons express MRGPRA3, and these are restricted to small-diameter neurons that innervate the stratum granulosum of the epidermis, providing one biological reason for itch arising from skin and not from deeper tissues 29 . By expressing a green fluorescent protein (GFP) in MRGPRA3-expressing neurons, the cell bodies of these rare neurons were identified in both dissociated cells in vitro and in situ in the DRG of an intact mouse 29 . This enabled researchers to position an electrode at the cell body of the MRG-PRA3-expressing neuron and to record neuronal activity evoked by stimuli applied to the neuron's cutaneous receptive field in vivo. Most or all MRGPRA3-expressing neurons responded with sustained action potential activity to histamine and to other pruritogens that had previously been shown 29, 32 to activate the cell bodies of these neurons in vitro. The MRGPRA3-expressing neurons also responded to mechanical and noxious heat stimuli and to the (painful) intradermal injection of capsaicin. Selective ablation of MRGPRA3-expressing neurons by diphtheria toxin reduced itch behaviour in response to histamine and certain other pruritogens, but it did not affect itch produced by β-alanine (an agonist for MRGPRD, a receptor expressed in another neuronal population 13 ) or the responses to painful stimuli 29 . These findings suggest that activity in MRG-PRA3-expressing neurons activates an afferent pathway that signals itch and not pain but that itch is not exclusively mediated by these MRGPRA3-expressing neurons.
Using an activity-dependent silencing strategy (namely, application of a charged sodium channel blocker, QX314, together with a specific pruritogen), a recent study found that histamine-induced scratching is also mediated by MRGPRA3-negative neurons 31 . There is no single molecular marker available to genetically label this MRGPRA3-negative, histaminesensitive neuronal population. Therefore, an intersectional strategy (for example, using a combination of two recombinase systems to express a transgene in overlapping cell types defined by two driver genes) 42 may be required to enable the genetic manipulation of MRGPRA3-negative neurons.
Pruriceptors responsive to other pruritogens. Virtually all CMH nociceptors in monkeys and humans, about half of the CMHs tested in the mouse and a subset of A-fibre MSAs tested in monkey respond to native cowhage spicules 14, [20] [21] [22] [23] , which elicit a histamine-independent itch 9, 10 . The mean peak discharge rates of these MSAs in the monkey are typically greater in response to cowhage than to a histamine injection 14 . When compression block of a peripheral nerve was used to eliminate conduction in A-but not C-fibres, cowhage-evoked itch and nociceptive sensations were reduced or eliminated in some trials but remained unaffected in others. These findings provide evidence that both A-and C-fibre MSAs . Each transducer element is a symbol for, not an actual representation of, a biological structure. There are two main types of nociceptors: those that respond to pruritic chemicals and those that do not (pruriceptive and non-pruriceptive nociceptors, respectively). Both types of nociceptor also respond to one or more noxious stimuli (mechanical or heat stimuli or a capsaicin injection) that elicit pain and not itch. The symbols illustrate some of the receptors expressed by each subtype. In mice, some pruriceptive nociceptors have been shown to express the receptor for chloroquine, Mas-related G-protein-coupled receptor member A3 (MRGPRA3), and the receptor for bovine adrenal medulla 8-22 peptide (BAM8-22), MRGPRC11. Primates have been shown to express the receptor for either of these ligands (MRGPRX1) in a subset of nociceptors. The transduction of the protease contained in cowhage is poorly understood but is hypothesized to involve proteinase-activated receptor 2 (PAR2) and/or PAR4. Other receptors shown are for histamine (H1), β-alanine (MRGPRD), capsaicin, noxious mechanical stimuli (mechanoreceptors) and heat that is transduced either by transient receptor potential vanilloid 1 (TRPV1) or by a mechanism independent of TRPV1. For clarity, other combinations of the receptors shown or other markers associated with nociceptive and pruriceptive transduction (such as TRPA1 (transient receptor potential cation channel ankyrin 1),TRPM8 (transient receptor potential cation channel, subfamily M, member 8) and P2X3 (purinergic receptor 2X, ligand-gated ion channel, 3)) or intracellular signalling are omitted.
can mediate cowhage-evoked sensations and support the idea that the relative contribution of each fibre type depends on which one happens to be activated at a skin test site 22 . The cellular mechanisms through which cowhage elicits action potentials in MSAs are largely unexplored. The active pruritic agent in cowhage spicules, a cysteine protease, might activate receptors directly on the sensory neuron such as PAR2 and/or PAR4 (REF. 43 ). For example, SLIGRL-NH2, the peptide ligand of PAR2 that elicits a histamine-independent itch in mice, can activate dissociated DRG neurons presumably via PAR2 or MRGPRC11 (REF. 33 ). In addition, or alternatively, keratinocytes possess many chemosensitive receptors and could be a source of neuroactive pruritic mediators that might activate pruriceptive neurons. For example, SLIGRL-induced activation of PAR2 receptors on keratinocytes causes these epithelial cells to release thymic stromal lymphopoietin (TSLP), a cytokine that plays a part in atopic dermatitis; TSLP, in turn, can directly activate a subset of TRPA1-positive cutaneous sensory neurons to elicit itch-like behaviour 44 . In primates, MRGPRX1 shares sequence homology with members of the mouse MRGPRA and MRGPRC subfamilies, is restricted to small-diameter DRG neurons and is activated by both chloroquine and BAM8-22 (REF. 32 ). In addition to cowhage, other chemical agents such as BAM8-22 or β-alanine that elicit a histamineindependent itch in humans 12, 13 can activate one or more subsets of CMHs in mice 13, 29 and monkeys 45 . Some of these CMHs, when electrophysiologically recorded in vivo, are also responsive to histamine. For example, in mice, most MRGPRA3-expressing CMH neurons responded to histamine, cowhage and BAM8-22 (although not to β-alanine) 29 (FIG. 2) . By contrast, another subset of CMH neurons, identified by the expression of GFP under the control of the MRGPRD promoter, responded to β-alanine but not to histamine 13 . However, this subset comprised only about 40% of the total number of MRGPRD-GFP neurons. The β-alanine unresponsive MRGPRD-GFP neurons were mechano-sensitive but heat-unresponsive nociceptors. None of the MRGPRDexpressing neurons responded to capsaicin or to other pruritic chemicals tested 13 (FIG. 2) .
MRGPRD-expressing neurons, like those expressing MRGPRA3, innervate only the epidermis of the mouse 29, 46 , consistent with a role in itch, which originates specifically from skin. Cellular studies in mice have indicated that MRGPRD-expressing neurons bind isolectin-B4 (IB4), do not produce neuropeptides and do not express MRGPRA3 or TRPV1 (REFS 29, 46) . Those that respond to heat may do so through a TRPV1-independent mechanism 28,47 (FIG. 2) . Deletion of the Mrgprd gene in mice abolished behavioural responses to β-alanine (without affecting responses to histamine) 13 . However, mice in which MRGPRD-expressing neurons were ablated also exhibited decreased behavioural sensitivity to noxious mechanical stimuli 48 . More information is required to determine whether β-alanine-sensitive and -insensitive types of MRGPRD neurons mediate itch, pain or both sensations.
In summary, there is diversity in the capacities of primary, cutaneous nociceptive sensory neurons in mice and primates to signal mechanical, thermal and chemical noxious stimuli. Some of these neurons are pruriceptive -that is, they have the additional capability of signalling the presence of one or more types of chemicals that elicit a sustained itch -whereas others (non-pruriceptive neurons) do not. 49, 50 .
Pruriceptive projections to the brain
In vivo electrophysiological recordings in the monkey were obtained from STT neurons that are responsive to noxious thermal, chemical and/or mechanical stimuli [51] [52] [53] . Approximately two-thirds of these nociceptive neurons were non-pruriceptive. The other one-third was pruriceptive and responded either to histamine or to cowhage spicules, but individual neurons rarely responded to both of these pruritic agents 52, 53 . Most of these pruriceptive STT neurons responded with greater discharge rates to heat and/or capsaicin than to either pruritic agent. The types of primary afferents delivering the input, directly or polysynaptically (through interneurons), to these STT neurons could not be determined in these in vivo studies. Nevertheless, in FIG. 3 we summarize our current understanding of the functional properties of nociceptors (in mice and primates) and STT neurons (in primates), and present a hypothetical scheme for the peripheral input to the pruriceptive and non-pruriceptive nociceptive STT neurons in primates.
Matching pruriceptive neuron activity to itch sensation.
One criterion for the encoding of pruritic information by both pruriceptors and pruriceptive STT neurons is that their responses to a pruritic chemical should match the time course of the sensation of itch: that is, the onset of the response should coincide with the beginning of the itch and the response should reach a peak and decline at approximately the same time as the itch. Assuming that humans and monkeys experience the same itch in response to histamine or to cowhage, this criterion is supported by the finding that there is a correspondence in the time course of mean sensory ratings of itch by humans 7, 9 and mean discharges of peripheral and STT pruriceptive neurons as electrophysiologically recorded in the monkey 14, 22, 53 (FIG. 4) . Specifically, for both the delivery of cowhage spicules and the intradermal injection of histamine, the time course of itch in Nature Reviews | Neuroscience Nevertheless, there are caveats and issues to resolve. First, it is not known whether the discharges in these neurons mediate itch alone or whether they also convey the minor nociceptive sensations that accompany the itch elicited by a pruritic chemical, which are typically of a slightly lesser magnitude and have a shorter time course 7, 9 . Second, potential input to STT neurons Non-pruriceptive nociceptors include those that respond only to noxious mechanical stimuli and mechanically insensitive nociceptors expressing transient receptor potential vanilloid 1 (TRPV1) (outlined in red) . The nociceptors outlined in green respond to one or more pruritic chemicals and also to one or more noxious stimuli. On the right, the schematic shows how these different types of peripheral sensory neurons might provide input to three types of nociceptive spinothalamic tract (STT) neurons, based in part on information obtained in the monkey. All three types of STT neurons respond to noxious heat, capsaicin and/or mechanical stimuli but one pathway (red) is non-pruriceptive, whereas the other two are pruriceptive (green). The pruriceptive neurons consist of two populations: STTs that are more responsive to cowhage than to histamine (light green) and thus presumably receive a dominant input from C-and A-fibre mechano-sensitive afferent (MSA) neurons and STTs that are more responsive to histamine than to cowhage (dark green) and receive a dominant pruriceptive input from histamine-responsive mechanically insensitive afferent (MIA) neurons. The synaptic mechanisms by which each type of afferent fibre contacts the STT neurons are unknown but may include a direct monosynaptic input and, through one or multiple interneurons, polysynaptic input (not shown). Action potential activity in the STT neurons is also subject to modulation by excitatory and inhibitory interneurons (not shown) as described in FIG. 5 . The image also shows the relatively greater spatial spread of a noxious stimulus or pruritogen when it is applied by injection than when it is applied by a spicule (as illustrated by the size of the shaded area on the left). DRG, dorsal root ganglion; H1, histamine H1 receptor; MRGPR, Mas-related G-protein-coupled receptor; PAR, proteinase-activated receptor. from other types of pruriceptive nerve fibres needs to be evaluated. These include peripheral neurons responsive to β-alanine or BAM8-22 (an important question is whether these neurons activate only cowhage-responsive STT neurons) and the MIAs with C fibres that are responsive to histamine. The recorded discharges of the latter require quantitative analyses, but it is thought that they are likely to make an important contribution to histamine-induced itch 6, 18 . In addition, there is indirect psychophysical evidence for an 'anti-pruritic' effect of a histamine injection that might be attributable to the activation of nociceptive afferents, which in turn may act centrally to limit the histamine-induced activity in pruritic nociceptive afferents 54 . In other words, not all pruriceptive neurons may act to mediate itch; some may act to reduce itch. Third, at present there is no means of molecularly identifying and selectively activating or deleting a particular type of STT neuron in primates (or mice) in order to link a particular ascending pathway to behaviour.
Modulation of pruriceptive information
Input from spinal interneurons as well as from descending pathways, such as those that originate in the brainstem, exert excitatory and inhibitory effects on projection neurons 55 , thereby potentially modulating transmission of pruriceptive information in the dorsal horn. Removal the homeobox gene T-cell leukaemia homeobox 3 (TLX3) in select spinal neurons during development 56 or the deletion of testicular receptor 4 (TR4), an orphan nuclear receptor 57 , leads to a loss of excitatory interneurons in the superficial dorsal horn and a significant attenuation of both itch and pain behaviour.
Recent findings have revealed several candidate neurotransmitters that may mediate transmission of pruritic information in the dorsal horn. Gastrin-releasing peptide (GRP) and its receptor (GRPR) are promising candidates for an itch-specific peptide transmitter and receptor in primary and secondary neurons, respectively. Ablation of a subset of dorsal horn neurons expressing GRPR in mice eliminated scratching in response to various chemical pruritogens 58, 59 . However, a recent study found that natriuretic peptide B (NPPB), rather than GRP, may be the itch-specific neurotransmitter expressed in pruriceptive MRGPRA DRG neurons 60 . In addition, this study found that GRP is not expressed by DRG neurons but rather by secondary dorsal horn neurons that express the NPPB receptor (NPRA) and presumably release GRP to activate GRPR-expressing tertiary neurons. Additional experiments are needed to prove that pruritogens cause DRG neurons to release NPPB to activate NPRA in dorsal horn neurons, to determine what types of neurons the NPRA-expressing neurons are and to examine whether NPRA is also expressed in DRG neurons that mediate inflammatory pain (as previously found in the rat 61 ). In addition to GRP and NPPB, glutamate and substance P probably have a role in the spinal transmission of pruriceptive input: histamine-induced scratching was completely blocked by an AMPA-kainate receptor antagonist but unaffected by a GRP or a neurokinin 1 (NK1) antagonist 62 . By contrast, chloroquine-induced, histamineindependent scratching behaviour was abolished by a combination of GRP-, NK1-and AMPA-kainate receptor antagonists 62 . Figure 4 | Pruriceptive neuronal activity matches the time course of itch sensation. The mean perceived intensity of itch in humans and the mean discharge rates of primary afferents and spinothalamic tract (STT) neurons recorded in monkeys are shown (n refers to the number of human subjects or number of nerve fibres or STT neurons tested). The responses of pruriceptors -that is, mechanoheat-sensitive C-fibres and mechano-sensitive A-fibre nociceptors -to cowhage and histamine are compared to the responses of pruriceptive STT neurons to the same stimuli. The responses of each neuron and each subject were normalized to the peak value obtained for that subject or neuron for a given pruritic agent (baseline activity for each STT is subtracted from the responses). Assuming that similar sensations are present in monkeys and humans, the finding that itch begins with the onset of activity in these neurons, reaches a peak magnitude and declines in approximate correspondence with this activity suggests that the itch is mediated at least in part by the activity of these neurons. Data obtained from REFS 7,9,14,22,53. Nature Reviews | Neuroscience Although some interneurons in mice seem to be crucial for the transmission of chemically evoked itch from the skin, others act to prevent spontaneous itch or to reduce stimulus-evoked itch. Indeed, behavioural signs of enhanced stimulus-evoked and spontaneous itch occur after removal of the vesicular glutamate transporter 2 (VGLUT2) in nociceptors, which results in reduced glutamate activation of pain-mediating neurons that normally act to reduce itch transmission in the CNS 63, 64 . Similarly, a loss, in the superficial dorsal horn, of itch inhibiting interneurons that express the transcription factor basic helix-loop-helix domain-containing, class B5 (BHLHB5) 65, 66 increases itch-related behaviour (FIG. 5a) . Opiates also modulate the transmission of pain and itch in the dorsal horn. Intrathecally administered morphine produces analgesia in humans and animals but, as a side effect, it can elicit itch and scratching behaviour 67, 68 . Electrophysiological recordings from nociceptive trigeminothalamic tract neurons in the medullar dorsal horn in the rat provided a correlate to the analgesic and pruritic effects of intrathecally delivered morphine: morphine excited and increased the responses of pruriceptive neurons to a chemical pruritogen, whereas it inhibited the non-pruriceptive neurons that selectively transmitted signals elicited by painful stimuli 69 . It is likely that morphine indirectly affected these projection neurons by acting on opiate receptors on primary afferent terminals or on spinal interneurons. For example, there may be an inhibition of interneurons that suppress pruriceptive transmission (FIG. 5a) . However, a recent study provides evidence that morphine-induced analgesia and itch are mediated in parallel by different isoforms of μ-opioid receptor 1 (MOR1) and MOR1D, respectively, and that MOR1D, by heterodimerizing with GRPR, activates the GRPR-expressing pruriceptive neurons 70 . Pruritic and algesic chemical stimuli can induce persistent and enhanced, mechanically evoked itch or pain within the region of application and in the surrounding skin area (known as primary and secondary dysesthesias, respectively). In the skin surrounding a local site of pruritogen application, itch is sometimes evoked by innocuous tactile stroking of the skin (alloknesis), and/ or there may be enhanced, mechanically evoked pricking pain (hyperalgesia) or itch (hyperknesis) 7, 9 (FIG. 6) .
One or more of these abnormal, unpleasant states or dysesthesias may outlast the itch, sometimes by an hour or longer. Similarly, an intradermal injection of capsaicin produces mechanically evoked hyperalgesia and sometimes also hyperknesis 7 that can long outlast the chemically evoked pain but, in contrast to the effects of a pruritogen, produces allodynia (pain or tenderness to innocuous stroking) rather than alloknesis 7, 71 . Some pruriceptive and non-pruriceptive projection neurons in the spinal dorsal horn become sensitized (in a process known as central sensitization) after pruritic or algesic chemical stimulation, thereby providing a possible substrate for mechanical secondary dysesthesias. After an injection of histamine, a small number of histamineresponsive STT neurons in the monkey exhibit increased responses to mechanical stroking or to punctate indentation of the skin with a probe that evokes pricking pain in humans 51, 53 . That is, these neurons become sensitized, and such sensitization, if maintained chronically, might contribute to the itch evoked by painful stimuli in patients with atopic dermatitis 72 . Similarly, many non-pruriceptive nociceptive STT neurons in monkeys become sensitized to mechanical stimuli after an injection of capsaicin 51, 73 . Although there are studies of the cellular mechanisms of central sensitization 74 , the neural circuitry (FIG. 6b ) underlying secondary dysesthesias induced by pruritic (or algesic) stimuli that typically occur in response to mechanical stimuli remains to be determined. It is particularly puzzling that after a capsaicin injection the incidence and magnitude of sensitization are greater in both non-pruriceptive and pruriceptive STT neurons 51 . Whether enhanced mechanically evoked activity in these two populations of neurons will result, for example, in alloknesis or allodynia may be determined by a suprasegmental decoding mechanism.
Itch can be selectively suppressed by noxious stimulation or by a state of hyperalgesia or allodynia. In the presence of certain types of chronic pain, histamine applied to neuropathic hyperalgesic skin can elicit pain instead of itch 75 . Similarly, itch is suppressed within an area of allodynia surrounding the site of an injection of capsaicin 76 (FIG. 6) .
Ongoing noxious stimulation can sometimes suppress an ongoing experimentally produced itch 77 . In monkeys, the responses of pruriceptive STT neurons to histamine are suppressed when the skin is scratched 78 Figure 5 | Models of modulation of itch transmission in the dorsal horn. a | The activity of pruriceptive (green) spinothalamic tract (STT) neurons is influenced by opposing inputs from excitatory and inhibitory interneurons. Here, the excitatory interneuron remains active (blue), whereas the inhibitory interneuron is either silenced (grey), for example, by activation of an opiate receptor by intrathecal morphine 69 or absent as a result of elimination of inhibitory interneurons, such as those expressing the transcription factor basic helix-loop-helix domain-containing, class B5 (BHLHB5) 65 . This results in the generation of 'spontaneous' itch sensations. b | Pruriceptive afferents selectively sensitize (dashed line) interneurons that receive input from low-threshold mechanoreceptors. As a result, a pruriceptive STT neuron exhibits enhanced responses to innocuous tactile stimuli (to induce tactile alloknesis). c | Simultaneous activity in histamine-responsive pruriceptive neurons and activity generated by scratching in non-pruriceptive (red) mechano-sensitive nociceptors, activate an interneuron (blue) that inhibits a pruriceptive STT neuron (modified from an 'and-gate' model 78 ). All STT neurons are also subject to modulation by suprasegmental descending pathways that are not shown. For simplicity, both the neurotransmitters and their receptors that are thought to be involved in the itch circuit are not included. Nature Reviews | Neuroscience 
'Labelled line' pathway
A pathway serving a particular sensory quality, such as itch. When selectively activated, it will elicit that type of sensation regardless of the type of activating stimulus, (FIG. 5c) . However, in the same neurons capsaicin-induced responses were increased by scratching. This may be due to the action of excitatory interneurons receiving input from non-pruriceptive, capsaicin sensitive, mechanically insensitive nociceptors. In mice, responses of dorsal horn neurons to pruritogens are decreased by scratching and this effect is prevented by the application of antagonists of the inhibitory neurotransmitters glycine and GABA that are released from interneurons 79 . However, pruriceptive dorsal horn neurons in mice, like the STT neurons in monkeys, are normally excited by noxious stimuli. Therefore, the neural circuitry governing the distinction between itch and pain does not occur in the dorsal horn and is probably located in the brain.
How is itch decoded? As described above, neurons that respond to pruritic stimuli are a subgroup of nociceptive neurons. This raises the issue of how information contained in the activity of these neurons might be used by the brain to produce the specific sensation of itch. In the following section, we review some of the models that have been proposed to address this problem.
Specificity and population models. The classical notion of specificity is that there are peripheral sensory neurons that are activated solely by pruritic stimuli (but not by other stimuli, such as those that evoke pain) causing activation of a 'labelled line' pathway in the CNS that produces itch. But although there are peripheral neurons with receptors for specific chemical pruritogens, these neurons also respond to noxious stimuli that evoke pain (FIG. 7a) . So, would the selective activation of a certain type of pruriceptive neuron, such as those expressing the MRGPRA3 receptor, elicit itch or pain? To address this question, a transgenic mouse in which TRPV1 is expressed only in MRGPRA3-positive neurons was generated 29 . In these mice, a capsaicin injection (normally painful) into the cheek evoked scratching (indicative of itch) and not wiping (indicative of pain) presumably because only pruriceptive MRGPRA3 neurons were activated and the nonpruriceptive neurons that mediate pain could no longer respond to capsaicin (FIG. 7b) . The findings suggest one mechanism by which the brain might decode itch from pain: the selective activation of these neurons -even by a noxious stimulus -elicits itch and it is the action potentials in these neurons and not the stimulus itself that are linked to itch (which is consistent with Müller's doctrine of specific nerve energies 86 ). However, action potentials in these pruriceptive neurons are not always sufficient for itch to occur. In wildtype mice (and presumably in humans), noxious stimuli such as a capsaicin injection, or noxious heat or mechanical stimuli, typically elicit pain rather than itch, possibly because of the simultaneous activation of non-pruriceptive and pruriceptive nociceptors. Supporting evidence for this concept was obtained from transgenic mice in which VGLUT2 was deleted from most nociceptive neurons 64 . This deletion resulted in spontaneous itch, a decrease in pain behaviour and a loss of the inhibition of itch by pain, such that an intradermal injection of capsaicin (normally painful) evoked itch and not pain behaviour. An analogous result was obtained after silencing putative pain-mediating neurons thought to express both TRPV1 and TRPA1 (REF. 31 ). Specifically, after injecting the skin with a charged sodium channel blocker that . Histamine can evoke alloknesis but not allodynia (that is, it can evoke itch but not pain or tenderness, in response to gentle stroking), whereas the reverse is true after capsaicin. In addition, the area of allodynia is 'anti-pruritic' -that is, itch cannot be elicited by injection of histamine 76 . b | The schematic shows that chemosensitive nociceptive primary afferents differ in their central projections and capacities to selectively enhance (sensitize, shown by dashed lines and + symbols) the responses of a projection neuron to certain types of input (tactile receptors are used as an example). Pruriceptive primary afferents, such as those responsive to histamine, enhance the responses of some but not all pruriceptive (P) spinothalamic tract (STT) neurons. Non-pruriceptive nociceptive primary afferents that respond to capsaicin are capable of sensitizing some, but not all, non-pruriceptive (N) STT neurons, thereby contributing to tactile allodynia. The presence of allodynia blocks (indicated by the -symbol) the occurrence of itch and alloknesis. selectively silenced neurons expressing either TRPA1 or TRPV1, a subsequent injection of either capsaicin or allyl isothiocyanate evoked itch and not the usual pain behaviour. The itch was thought to result from the activation of TRPA1 or TRPV1 in pruriceptive neurons without the activation of the hypothesized pain-mediating neurons that express both receptors 31 . The implication of these findings is that under normal conditions (in wild-type mice), sufficient activation of pain-mediating neurons somehow prevents or masks the effects of simultaneous activity in pruriceptive neurons, resulting in pain without itch. This would be consistent with a 'population theory' of the neural code upon which itch is based 80 . Thus, whether an itch or pain sensation occurs depends on the relative activity in neurons constituting two labelled lines, one for itch and one for pain, such that a sufficiently greater activity in pruriceptive compared to non-pruriceptive ). The schematic illustrates how the sensation of itch may be derived from both the specific types of neurons that are activated as well as the number and distribution of the neurons activated (as predicted by the 'population', 'intensity' and 'spatial contrast' models of itch) (see main text). H1, histamine H1 receptor; PAR, proteinase-activated receptor; TRPV1, transient receptor potential vanilloid 1. nociceptive (and perhaps also non-nociceptive) neurons would result in itch. The neural mechanisms by which the brain assesses the relative number and discharge rates of different populations of neurons are, however, unknown.
Intensity and temporal pattern models. There is insufficient support for the idea that itch and pain are mediated solely by weaker activation and stronger activation, respectively, of the same types of nociceptors or that they are distinguished by differences in the temporal pattern of activation 81 . When itch was elicited in humans by a train of electrical pulses delivered to the skin, alterations in the pulse frequency (and presumably the discharge rate in pruriceptive cutaneous neurons) altered only the degree of itch and did not elicit pain; similarly, changes in the temporal pattern of stimulation did not turn itch to pain or vice versa 82, 83 . The responses of STT neurons to both pruritic agents and capsaicin are bursting in nature 53 . Although the interburst interval is shorter in response to capsaicin, which might provide a temporal code for pain (versus itch), this may reflect differences in sensory intensity, as capsaicin is likely to be perceived as producing a more intense sensation by humans 7 . However, pruritogens elicit much lower rates of discharge than moderately painful stimuli (such as heat and capsaicin) in peripheral and STT neurons 53 . The idea that discharge rates and perhaps the number of activated nociceptive neurons (and low-threshold neurons as well) have a role in a central neural mechanism that compares activity in different populations of neurons to produce itch has not been ruled out.
Spatial models.
There is little evidence that the particular spatial pattern of nerve impulse activity in nociceptive neurons determines whether itch or pain occurs 81 . Instead, it has been proposed that itch may occur when there is a 'spatial contrast' between the activity of one or a few nociceptive cutaneous nerve fibres (even if non-pruriceptive) and the absence of activity in neighbouring nociceptive fibres supplying the same and surrounding region of skin 20, 84 . Thus, a cowhage spicule, or a spicule containing only capsaicin 11 , probably activates only a few CMH nociceptive nerve endings, whereas a pinch, a hot probe or an injection of capsaicin applied to the skin would activate a larger and spatially coherent population of the same and/or other types of nociceptors (FIG. 7) . Similarly, histamine activated a larger population of CMH nociceptors (and triggered greater discharge rates) in the rat when preceded by an application of bradykinin, a sensitizing algogen; and, when preceded by bradykinin in humans, histamine elicited burning instead of itch 85 . Thus, it might be argued that if a small population of non-pruriceptive nociceptorssimilar in size to the MRGPRA3-expressing neuronal population -could be selectively activated, itch-and not pain behaviour could be induced in mice. In that case, a labelled line might not be essential. However, some observations do not seem to fit with this notion of spatial contrast. For example, humans do not rate itch as decreasing in magnitude in relation to pain with an increase in the dose of histamine or with an increase in the spatial area of skin exposed to histamine when it is injected versus applied by a single spicule 7, 11 , despite the fact that such increases might be expected to activate a greater number of pruriceptors.
Conclusions and future directions
The generation of chemically evoked itch begins with action potential activity in a subset of peripheral cutaneous nociceptors (pruriceptors) and the concurrent activity of a subpopulation of pruriceptive STT nociceptive neurons that convey pruritic stimulus information to the brain. In monkeys, discharges from these neurons correlate with the time course of itch in humans. In a genetically engineered mouse with restricted expression of the capsaicin receptor, selective activation of a class of pruriceptors by capsaicin elicits itch-like and not pain-like behaviour. Pruriceptive neurons readily respond to noxious stimuli that elicit pain, a feature that they share with non-pruriceptive peripheral and STT nociceptive neurons. These pruriceptive and non-pruriceptive neurons are therefore regarded as subclasses of nociceptive neurons. Itch may result from activity in the pruriceptive neurons in the absence of sufficient activity in non-pruriceptive neurons. Itch transmission can be enhanced or reduced in the spinal or medullary dorsal horn. The neural circuitry hypothesized to evaluate the relative activity in pruriceptive and non-pruriceptive neuronal populations and to decode itch from pain is unknown, but it is likely to reside in suprasegmental regions of the brain.
To further our understanding of the neural activity associated with itch, it will be useful to record, in vivo, from projection neurons and their neuronal targets in the midbrain, thalamus and cortex. In addition, cell-specific labelling and selective activation of different types of pruriceptive and non-pruriceptive peripheral or central projection neurons are needed to unravel the neuronal mechanism of itch. This might be accomplished in transgenic animals expressing a receptor that could be quantitatively activated, for example, by an optical stimulus, to generate different rates and patterns of action potential activity. One might be able to manipulate the number of neurons activated and the patterns of their discharge to assess the role of the number of afferents and their discharge rates in eliciting itch versus pain behaviour. This approach would provide experimental tests of the different models of the neuronal basis for itch.
There is also a need to determine the neural circuitry responsible for different types of central sensitization leading to alloknesis and hyperknesis versus allodynia and hyperalgesia and why secondary dysesthesias typically occur in response to mechanical but not to other types of stimuli. Ultimately, more electrophysiological experiments in the monkey and psychophysical experiments in humans are needed to help translate the findings of behavioural and molecular studies in rodent to experimental itch and itch disorders in humans. These studies will also be useful to differentiate further the neuronal mechanisms underlying the sensation of pain and itch in humans.
